A Kuwaiti specialist in stomach diseases has assured patients suffering from Crohn's that a new medication has proven effective in treating the disease.
The declaration about the new drug, Morgensen, was made during a European medical conference, held in Vienna, last week, said Dr. Fahad Al-Najjar, gastroenterologist (stomach), hepatologist (liver) and internist (internal medicine) specialist, in remarks to KUNA.
The new drug, known as as GED-0301 or Mongersen, is an antisense medication taken orally that has been well tolerated and induced remission in 72 percent of Crohn's disease patients studied. The medication could replace injections for treating IBD. The medication can be secured for Kuwaitis by 2017, Dr. Najjar told KUNA, also indicating that a company, which he did not name, had paid USD 3.2 billion to buy exclusives rights for marketing the new medicine.